Mckesson Corporation stock dividend – McKesson Corporation Declares Quarterly Dividend of $0.54 Per Share

Trending News ☀️

Mckesson Corporation stock dividend – MCKESSON ($NYSE:MCK): The company recently declared a quarterly dividend of $0.54 per share, in accordance with its previous payments. This dividend is payable on April 3 to shareholders of record on March 1 and ex-dividend on February 28. More information is available in the McKesson Dividend Scorecard, Yield Chart, and Dividend Growth page. McKesson is committed to delivering quality healthcare services and products to its customers.

The company is also committed to providing innovative products and services to help healthcare providers provide better patient care. The company’s commitment to delivering quality services combined with its strong financial performance makes it an attractive investment for many investors. With the recent announcement of its quarterly dividend, McKesson is providing investors with an additional incentive to invest in the company’s stock.

Dividends – Mckesson Corporation stock dividend

McKesson Corporation has announced a quarterly dividend of $0.54 per share, which marks a steady increase in the company’s dividends over the past three years. The 2021 dividend rate of $1.95 per share, the 2022 rate of $1.83 per share, and the 2023 rate of $1.67 per share all demonstrate the company’s commitment to rewarding shareholders with a healthy return on their investment. In addition to the quarterly dividend, investors are also able to take advantage of the company’s generous dividend yield program, which offers investors a yield of 0.63% in 2021, 0.63% in 2022, and 0.92% in 2023, with an average dividend yield of 0.73%. This dividend program is an excellent way for investors to gain access to a reliable and consistent stream of income, as McKesson Corporation has a history of increasing its dividends on a regular basis. The company’s commitment to rewarding shareholders is further evidenced by its recent announcement that it would be repurchasing up to $2 billion worth of its own common stock.

This will help further increase the value of the company’s shares, as well as provide an additional source of income for investors. In conclusion, McKesson Corporation’s commitment to rewarding shareholders is clearly demonstrated by its quarterly dividend program and its generous dividend yield program. The company’s recent announcement of a quarterly dividend of $0.54 per share is yet another example of the company’s dedication to providing investors with a reliable and consistent stream of income. As such, McKesson Corporation is an excellent choice for investors looking to benefit from a reliable and consistent stream of income.

About the Company

Income Snapshot

Below shows the total revenue, net income and net margin for Mckesson Corporation. More…

Cash Flow Snapshot

Below shows the cash from operations, investing and financing for Mckesson Corporation. More…

Balance Sheet Snapshot

Below shows the total assets, liabilities and book value per share for Mckesson Corporation. More…

Key Ratios Snapshot

Some of the financial key ratios for Mckesson Corporation are shown below. More…

Share Price

McKesson Corporation, a leading healthcare services and information technology company, announced on Thursday that it would declare a quarterly dividend of $0.54 per share. McKesson Corporation’s stock opened at $377.0 and closed at $384.1 on Thursday, which is 2.1% higher than its last closing price of $376.0. The company’s board of directors has approved the dividend increase based on its solid financial position and belief that the company’s long-term growth potential remains strong. The company’s strong financial position and continued growth prospects have been supported by its focus on improving operational efficiency, expanding its product portfolio, and developing innovative solutions that help customers improve patient care and reduce costs.

McKesson Corporation is also investing in digital technologies to further strengthen its market position and drive growth in the future. Overall, the quarterly dividend increase announced by the McKesson Corporation is a strong indication of the company’s commitment to its shareholders and its confidence in its long-term growth prospects. This dividend declaration demonstrates the company’s dedication to returning value to its shareholders and supporting their financial goals. Live Quote…

VI Analysis – Mckesson Corporation Stock Fair Value

McKesson Corporation is a healthcare company with a solid long-term potential. A quick look at the company’s fundamentals using the VI app provides an easy-to-understand assessment of the stock. According to the app, the intrinsic value of a McKesson Corporation share is around $265.5. This means that the current stock price of $384.1 is overvalued by 45%. This could be a good opportunity for investors to buy in, if they believe in the company’s long-term potential. The app’s analysis also reveals that the company is currently overvalued considering its price/book ratio and price/sales ratio. Additionally, its cash flow and dividend yield are both below average. In conclusion, a detailed analysis of McKesson Corporation reveals that it is currently overvalued. However, investors could still benefit from purchasing shares if they believe in the company’s long-term potential. The app’s analysis provides a quick and easy assessment of the stock, making it easy to understand the company’s fundamentals and make informed decisions. More…

VI Peers

In the healthcare sector, McKesson Corp competes against Cardinal Health Inc, AmerisourceBergen Corp, and Sigma Healthcare Ltd. These companies are all major players in the healthcare industry, and each one brings something unique to the table. However, McKesson Corp is the largest of these companies, and its size gives it a significant competitive advantage.

– Cardinal Health Inc ($NYSE:CAH)

Cardinal Health Inc is a healthcare services and products company that operates in two segments: Pharmaceutical and Medical. The company’s Pharmaceutical segment includes sales of branded, generic and over-the-counter pharmaceutical products, as well as nuclear pharmacy services. The Medical segment provides a range of medical products and services, including surgical and medical products, medical devices and laboratory products and services. Cardinal Health Inc has a market cap of 18.55B as of 2022. The company’s Return on Equity for the same period is 55.12%.

– AmerisourceBergen Corp ($NYSE:ABC)

AmerisourceBergen is one of the world’s largest pharmaceutical services companies. It offers a range of services and products to healthcare providers and pharmaceutical companies. The company has a market cap of 29.64B as of 2022 and a return on equity of 417.0%. AmerisourceBergen is a publicly traded company listed on the New York Stock Exchange.

– Sigma Healthcare Ltd ($ASX:SIG)

Sigma Healthcare is a leading full-line wholesale and distribution company that services pharmacies across Australia. The company has a market capitalisation of $693.83 million as of March 2022 and a return on equity of 0.46%. Sigma Healthcare is a diversified healthcare company with operations in both pharmacy and hospital sectors. The company’s primary activities include the wholesale distribution of pharmaceuticals, medical and surgical supplies. Sigma Healthcare also owns and operates a number of community pharmacies across Australia.

Summary

McKesson Corporation, a global healthcare services and IT company, has declared a quarterly dividend of $0.54 per share. For investors looking to benefit from McKesson Corporation’s strong financial performance and attractive dividend yield, now is an opportune time to consider investing in the company.